Insider · CIK 0001191229

KARABELAS ARGERIS N

Reports to the SEC for 8 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001191229

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-29	RGNXREGENXBIO Inc.A Award	Director	AAward	+9,807 sh	—	—	28,861
2026-05-29	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+46.6K sh	—	—	46,600
2025-05-30	RGNXREGENXBIO Inc.A Award	Director	AAward	+7,768 sh	—	—	19,054
2025-05-30	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+39.8K sh	—	—	39,815
2024-10-01	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.76	+$37.6K	21,286
2024-10-01	RGNXREGENXBIO Inc.S Sale	Director	SSale	−10K sh	$10.11	−$101K	11,286
2024-10-01	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2024-09-03	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.76	+$37.6K	21,286
2024-09-03	RGNXREGENXBIO Inc.S Sale	Director	SSale	−9,300 sh	$11.50	−$107K	11,986
2024-09-03	RGNXREGENXBIO Inc.S Sale	Director	SSale	−700 sh	$12.34	−$8,638	11,286
2024-09-03	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	10,000
2024-08-01	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.76	+$37.6K	21,286
2024-08-01	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+100 sh	$12.74	+$1,274	21,386
2024-08-01	RGNXREGENXBIO Inc.S Sale	Director	SSale	−9,600 sh	$13.45	−$129K	11,786
2024-08-01	RGNXREGENXBIO Inc.S Sale	Director	SSale	−400 sh	$14.59	−$5,834	11,386
2024-08-01	RGNXREGENXBIO Inc.S Sale	Director	SSale	−100 sh	$15.00	−$1,500	11,286
2024-08-01	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−100 sh	—	—	1,400
2024-08-01	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	20,000
2024-07-29	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11K sh	$12.74	+$140K	22,286
2024-07-29	RGNXREGENXBIO Inc.S Sale	Director	SSale	−11K sh	$15.04	−$165K	11,286
2024-07-29	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11K sh	—	—	1,500
2024-07-01	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.76	+$37.6K	21,286
2024-07-01	RGNXREGENXBIO Inc.S Sale	Director	SSale	−10K sh	$11.27	−$113K	11,286
2024-07-01	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	30,000
2024-05-31	RGNXREGENXBIO Inc.A Award	Director	AAward	+4,790 sh	—	—	11,286
2024-05-31	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+24.5K sh	—	—	24,454
2023-06-02	RGNXREGENXBIO Inc.A Award	Director	AAward	+3,486 sh	—	—	6,496
2023-06-02	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+17.9K sh	—	—	17,892
2022-06-24	BHCBausch Health Companies Inc.A Award	Director	AAward	+34.4K sh	—	—	123,715
2022-06-03	RGNXREGENXBIO Inc.A Award	Director	AAward	+3,010 sh	—	—	3,010
2022-06-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.3K sh	—	—	15,324
2021-06-04	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-04-30	BHCBausch Health Companies Inc.A Award	Director	AAward	+7,645 sh	—	—	89,328
2020-05-29	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-05-01	BHCBausch Health Companies Inc.A Award	Director	AAward	+11K sh	—	—	81,683
2019-05-31	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-05-03	BHCBausch Health Companies Inc.A Award	Director	AAward	+10.6K sh	$23.51	+$250K	70,646
2018-05-25	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-05-03	BHCBausch Health Companies Inc.A Award	Director	AAward	+13.9K sh	—	—	60,013
2018-05-03	BHCBausch Health Companies Inc.A Award	Director	AAward	+14.3K sh	—	—	60,417
2017-05-24	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2017-05-05	BHCBausch Health Companies Inc.A Award	Director	AAward	+25.4K sh	—	—	46,132
2016-08-11	BHCBausch Health Companies Inc.P Purchase	Director	PPurchase	+4,000 sh	$24.65	+$98.6K	20,726
2016-06-17	BHCBausch Health Companies Inc.A Award	Director	AAward	+16.7K sh	—	—	16,726
2016-06-01	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2015-09-16	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,208 sh	—	—	5,208
2015-09-16	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,375 sh	—	—	9,375
2015-06-24	RCKTROCKET PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	Director, 10% Owner	AAward	+12K sh	$5.03	+$60.4K	21,857
2015-02-23	RCKTROCKET PHARMACEUTICALS, INC.C Conversion	Director, 10% Owner	CConversion	+1.39M sh	—	—	1,609,747
2015-02-23	RCKTROCKET PHARMACEUTICALS, INC.C Conversion	Director, 10% Owner	CConversion	+63.6K sh	—	—	1,673,307

Recent filings

Accepted (ET)
Jun 24
KARABELAS ARGERIS N0001191229-26-000002
SEC(opens sec.gov)
Jun 34
KARABELAS ARGERIS N0001562180-25-004348
SEC(opens sec.gov)
Oct 24
KARABELAS ARGERIS N0001562180-24-007144
SEC(opens sec.gov)
Sep 44
KARABELAS ARGERIS N0001562180-24-006657
SEC(opens sec.gov)
Aug 54
KARABELAS ARGERIS N0001562180-24-006015
SEC(opens sec.gov)
Jul 304
KARABELAS ARGERIS N0001562180-24-005875
SEC(opens sec.gov)

Companies

Address

C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850